Halberd steps into the health metaverse

Halberd Corporation announces plans to enter the Metaverse by the creation of non-fungible tokens (NFT’s) to monetize certain intellectual properties of the company including but not limited to patents, patents pending, trade secrets, etc.

Halberd is currently in negotiations to engage a team of experts in Metaverse

The company Halberd is currently in talks with Metaverse to hire a team of experts with experience in non-fungible tokens (NFTs) who can identify growth opportunities by monitoring the evolving market, establishing category strategy, and managing key partners who are critical to our company’s success in this emerging sector.

The company intends to issue a series of non-fungible tokens (NFTs) in the future to represent its intellectual property rights, such as patents, patents pending, trade secrets, and so on. Furthermore, both shareholders and non-shareholders will be able to purchase these NTFs on the NFT market independently through a personalized electronic wallet (s). The owners will be granted tokenized rights to the company’s chosen intellectual properties.

Halberd’s Chairman, President, and CEO, William A. Hartman, remarked, “Our stockholders will benefit from increased liquidity as a result of this. This will be part of our full-service package, which will include professionals providing comprehensive counsel to shareholders throughout the process at no cost to them.

Not only will each shareholder own common shares in HALB, but they will also own intellectual property rights in the form of these tokens. Shareholders will not only own shares, but also a fundamental portion of the company, allowing them to access at least two different sources of liquidity. Halberd now owns the Medical MetaverseTM trademark.”

Halberd Corporation is a publicly traded company on the OTC Market

The company Halberd Corporation is an OTC Market publicly traded business that complies with all OTC Market reporting standards. Halberd has gained exclusive worldwide rights to three issued patents and submitted twenty related provisional, PCT, or utility patent applications to increase its stockholder value and draw the interest of possible development partners since its restructuring in April 2020.


Image credits: Shutterstock, CC images, Midjourney, Unsplash.